BR9808422B1 - composto, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto. - Google Patents

composto, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.

Info

Publication number
BR9808422B1
BR9808422B1 BRPI9808422-4A BR9808422A BR9808422B1 BR 9808422 B1 BR9808422 B1 BR 9808422B1 BR 9808422 A BR9808422 A BR 9808422A BR 9808422 B1 BR9808422 B1 BR 9808422B1
Authority
BR
Brazil
Prior art keywords
compound
preparation
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
BRPI9808422-4A
Other languages
English (en)
Other versions
BR9808422A (pt
Inventor
Eric Cleveland Bigham
Eric Eugene Boros
Grady Evan Boswell
Robert Anthony Mook
Sanjay Shashikant Patel
Vicente Samano
John Joseph Savarese
Roy Archibald Swaringen Jr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9706117.0A external-priority patent/GB9706117D0/en
Priority claimed from GBGB9724987.4A external-priority patent/GB9724987D0/en
Application filed filed Critical
Publication of BR9808422A publication Critical patent/BR9808422A/pt
Publication of BR9808422B1 publication Critical patent/BR9808422B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
BRPI9808422-4A 1997-03-25 1998-03-23 composto, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto. BR9808422B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9706117.0A GB9706117D0 (en) 1997-03-25 1997-03-25 Ultra-short acting neuromuscular blockers
GBGB9724987.4A GB9724987D0 (en) 1997-11-27 1997-11-27 Ultra-short acting neuromuscular blockers
PCT/EP1998/001651 WO1998042674A1 (en) 1997-03-25 1998-03-23 Substituted isoquinolines as ultra short acting neuromuscular blockers

Publications (2)

Publication Number Publication Date
BR9808422A BR9808422A (pt) 2000-05-23
BR9808422B1 true BR9808422B1 (pt) 2010-08-24

Family

ID=26311255

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9808422-4A BR9808422B1 (pt) 1997-03-25 1998-03-23 composto, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.

Country Status (37)

Country Link
US (2) US6187789B1 (pt)
EP (4) EP1526130A1 (pt)
JP (3) JP4112015B2 (pt)
KR (2) KR100578443B1 (pt)
CN (1) CN1203061C (pt)
AP (1) AP1797A (pt)
AR (1) AR012156A1 (pt)
AT (3) ATE430734T1 (pt)
AU (2) AU745382B2 (pt)
BR (1) BR9808422B1 (pt)
CA (1) CA2284802C (pt)
CO (1) CO4940499A1 (pt)
CZ (1) CZ293786B6 (pt)
DE (3) DE69840816D1 (pt)
DK (2) DK0975599T3 (pt)
EA (1) EA002224B1 (pt)
EE (1) EE04113B1 (pt)
ES (2) ES2210757T3 (pt)
HK (1) HK1023342A1 (pt)
HR (1) HRP980157B1 (pt)
HU (1) HU228230B1 (pt)
ID (1) ID22901A (pt)
IL (1) IL131918A (pt)
IS (2) IS2346B (pt)
MA (1) MA26476A1 (pt)
MY (1) MY121316A (pt)
NO (1) NO314726B1 (pt)
NZ (1) NZ337797A (pt)
PE (1) PE68399A1 (pt)
PL (1) PL190860B1 (pt)
PT (2) PT971898E (pt)
RS (1) RS49869B (pt)
SI (1) SI0975599T1 (pt)
TR (1) TR199902330T2 (pt)
TW (1) TW505635B (pt)
UY (1) UY24933A1 (pt)
WO (2) WO1998042675A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ337797A (en) * 1997-03-25 2001-03-30 Cornell Res Foundation Inc Substituted isoquinolines as ultra short acting neuromuscular blockers and their use in therapy
US6911455B2 (en) 1999-12-22 2005-06-28 Smithkline Beecham Corporation Methods for preparing pharmaceutical formulations
US6844904B2 (en) * 2002-12-07 2005-01-18 Cubic Corporation Fast PDLC device
EP1684753A2 (en) * 2003-10-28 2006-08-02 Cornell Research Foundation, Inc. Neuromuscular blocking agents and antagonists thereof
CN101588803B (zh) * 2006-12-06 2013-03-20 康乃尔研究基金会有限公司 中等持续时间神经肌肉阻断剂及其拮抗剂
US8461338B2 (en) * 2007-03-08 2013-06-11 Chemagis Ltd. (1R, 1′R)-atracurium salts separation process
AU2008231470A1 (en) * 2007-03-26 2008-10-02 Chemagis Ltd. (1R,1'R)-atracurium salts separation process
EP2142510A1 (en) * 2007-05-01 2010-01-13 Chemagis Ltd. Novel isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates
WO2008132748A1 (en) * 2007-05-01 2008-11-06 Chemagis Ltd. Process for producing cisatracurium compounds and associated intermediates
EP2132181A1 (en) * 2007-06-18 2009-12-16 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
US20100256381A1 (en) * 2007-07-09 2010-10-07 Chemagis Ltd. Process for producing cisatracurium and associated intermediates
BRPI0816519A2 (pt) 2007-10-29 2015-03-24 Chemagis Ltd Processo para preparar um sal de r, r'-atracúrio isomericamente enriquecido e sal de r, r'-atracúrio
WO2009133556A2 (en) * 2008-05-01 2009-11-05 Chemagis Ltd. Cisatracurium derivatives, preparation and uses thereof
WO2010107488A1 (en) * 2009-03-17 2010-09-23 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
US9220700B2 (en) 2009-08-19 2015-12-29 Cornell University Cysteine for physiological injection
WO2014005122A2 (en) * 2012-06-29 2014-01-03 Savarese John J Asymmetrical reversible neuromuscular blocking agents of ultra-short, short, or intermediate duration
CN103373959A (zh) * 2013-06-14 2013-10-30 安徽省先锋制药有限公司 顺式苄基异喹啉类化合物的制备方法及其用途
WO2014210369A2 (en) * 2013-06-28 2014-12-31 Cornell University Reversal of cysteine-inactivated neuromuscular blocking drugs with combinations of reversal agents
CN108375644B (zh) * 2016-12-07 2021-11-30 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂中间体的分析方法
CN108938573B (zh) * 2017-05-26 2021-08-10 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂组合物及其制备方法和用途
CN110776481B (zh) * 2018-07-24 2023-06-16 四川大学华西医院 一类双阳离子化合物及其制备方法和用途
CN109776486A (zh) * 2019-02-26 2019-05-21 武汉松石科技股份有限公司 一种硫酸亚丙酯的制备方法
CN111662230A (zh) * 2019-03-06 2020-09-15 四川道珍科技有限公司 一类苄基异喹啉化合物、制备方法和用途
CN110117297A (zh) * 2019-04-10 2019-08-13 珠海市赛纬电子材料股份有限公司 一种2-磷酸盐基硫酸丙烯酯的制备方法
TW202128628A (zh) * 2019-12-11 2021-08-01 大陸商江蘇恆瑞醫藥股份有限公司 神經肌肉阻滯劑及其製備方法
CN111471013B (zh) * 2020-05-26 2021-04-30 朗天药业(湖北)有限公司 一种米库氯铵及其注射液的制备方法
CN111909089B (zh) * 2020-08-14 2023-04-14 广东嘉博制药有限公司 一种米库氯铵对照品的制备方法
CN114057642B (zh) * 2021-12-10 2023-03-28 广东嘉博制药有限公司 一种米库氯铵中间体的合成方法
CN115073373A (zh) * 2022-07-08 2022-09-20 广东嘉博制药有限公司 一种不对称合成（r）-5’-甲氧基劳丹素的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004031A (en) * 1958-07-03 1961-10-10 Allen & Hauburys Ltd Diquaternary salts of papaverino esters
AU506657B2 (en) * 1975-12-10 1980-01-17 Wellcome Foundation Limited, The Isoquinoline derivatives
MC1197A1 (fr) * 1977-08-01 1979-03-19 Massachusetts Gen Hospital Composes tetrahydro-isoquinoleiniques myorelaxants(agents de blocage de la plaque neuro-musculaire)et leur preparation
US4701460A (en) * 1980-12-17 1987-10-20 Burroughs Wellcome Co. Long duration neuromuscular blocking agents
JPS5899465A (ja) * 1981-11-23 1983-06-13 ザ・ウエルカム・フアウンデ−シヨン・リミテツド イソキノリン誘導体
GB8418303D0 (en) * 1984-07-18 1984-08-22 Wellcome Found Compounds
BG41897A1 (en) * 1985-07-19 1987-09-15 Ivanov Dichlormethylate of n, n'- 4, 10- dioxa- 3, 11- bis- tetrahydropapaverine and method for its preparation
GB9015473D0 (en) 1990-07-13 1990-08-29 Wellcome Found Neuromuscular blocking agents
JPH04112016A (ja) * 1990-09-03 1992-04-14 Fuji Electric Co Ltd トランスファ成形金型用プランジャ及びトランスファ成形装置
US5240939A (en) * 1991-10-31 1993-08-31 Anaquest, Inc. Nitrogen bridge tetrahydroisoquinolines
NZ337797A (en) * 1997-03-25 2001-03-30 Cornell Res Foundation Inc Substituted isoquinolines as ultra short acting neuromuscular blockers and their use in therapy

Also Published As

Publication number Publication date
ID22901A (id) 1999-12-16
ATE254107T1 (de) 2003-11-15
EP0971898B1 (en) 2005-05-11
PL190860B1 (pl) 2006-02-28
EP1380573A2 (en) 2004-01-14
DE69830157D1 (de) 2005-06-16
US6187789B1 (en) 2001-02-13
TR199902330T2 (xx) 2000-02-21
JP2002503220A (ja) 2002-01-29
DK0975599T3 (da) 2004-03-15
EE9900424A (et) 2000-04-17
JP4112015B2 (ja) 2008-07-02
CA2284802A1 (en) 1998-10-01
HU228230B1 (en) 2013-02-28
EP0971898A1 (en) 2000-01-19
KR20050103984A (ko) 2005-11-01
ATE430734T1 (de) 2009-05-15
EP1380573A3 (en) 2004-01-21
CN1257483A (zh) 2000-06-21
DK0971898T3 (da) 2005-09-05
AU7521098A (en) 1998-10-20
JP2002517168A (ja) 2002-06-11
DE69819703T2 (de) 2004-09-30
NO994680L (no) 1999-11-24
IS8717A (is) 2008-03-03
MY121316A (en) 2006-01-28
UY24933A1 (es) 2000-12-29
JP4112016B2 (ja) 2008-07-02
EA002224B1 (ru) 2002-02-28
IS2346B (is) 2008-03-15
JP2008019272A (ja) 2008-01-31
ATE295351T1 (de) 2005-05-15
BR9808422A (pt) 2000-05-23
AU745382B2 (en) 2002-03-21
CZ293786B6 (cs) 2004-07-14
ES2242275T3 (es) 2005-11-01
EP0975599A1 (en) 2000-02-02
AP9901658A0 (en) 1999-09-30
CZ340499A3 (cs) 2000-04-12
US6177445B1 (en) 2001-01-23
NO994680D0 (no) 1999-09-24
HK1023342A1 (en) 2000-09-08
AR012156A1 (es) 2000-09-27
PT975599E (pt) 2004-03-31
KR20010005621A (ko) 2001-01-15
EP1526130A1 (en) 2005-04-27
PE68399A1 (es) 1999-07-23
DE69840816D1 (de) 2009-06-18
EE04113B1 (et) 2003-08-15
HRP980157A2 (en) 1999-02-28
KR100578443B1 (ko) 2006-05-11
EA199900756A1 (ru) 2000-08-28
HUP0001556A3 (en) 2002-01-28
WO1998042675A1 (en) 1998-10-01
IL131918A0 (en) 2001-03-19
EP0975599B1 (en) 2003-11-12
WO1998042674A1 (en) 1998-10-01
PL335885A1 (en) 2000-05-22
IL131918A (en) 2005-09-25
PT971898E (pt) 2005-07-29
DE69819703D1 (de) 2003-12-18
ES2210757T3 (es) 2004-07-01
CA2284802C (en) 2009-06-16
HUP0001556A2 (hu) 2001-04-28
HRP980157B1 (en) 2004-10-31
NZ337797A (en) 2001-03-30
RS49869B (sr) 2008-08-07
EP1380573B1 (en) 2009-05-06
AP1797A (en) 2007-11-15
DE69830157T2 (de) 2006-05-11
IS5185A (is) 1999-09-17
TW505635B (en) 2002-10-11
NO314726B1 (no) 2003-05-12
CN1203061C (zh) 2005-05-25
KR100554601B1 (ko) 2006-03-03
YU48399A (sh) 2002-06-19
CO4940499A1 (es) 2000-07-24
SI0975599T1 (en) 2004-04-30
MA26476A1 (fr) 2004-12-20
AU6730598A (en) 1998-10-20

Similar Documents

Publication Publication Date Title
BR9807814B1 (pt) composto de pirazina, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
BR9808422B1 (pt) composto, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
BR9810802B1 (pt) composto, composição farmacêutica, e, processo para a preparação de um composto.
BR9909995B1 (pt) composto, processo para a preparação de um composto, formulação farmacêutica, e, uso de um composto.
BR9810829B1 (pt) composto heterocìclico, processo para preparar o mesmo, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica.
BR9912109B1 (pt) compostos derivados de quinolina, composições farmacêuticas, processo para a manufatura de um composto, e, uso de um composto.
BR9806870B1 (pt) composto amidino, formulação farmacêutica, uso de um composto, e, processo papa preparar o mesmo.
BR9801606B1 (pt) composto, processo para sua preparação, substáncia farmacêutica, uso do composto e processo para a produção de uma substáncia farmacêutica.
BR9501770A (pt) Uso de um composto,composto,formulação farmacêutica e processo para preparar um composto
BR9911182B1 (pt) compostos derivados de biarila com propriedades agonistas de adrenorreceptores beta-3, uso de um composto, composição farmacêutica, e, processo para a preparação de um composto.
BR9602705A (pt) Composto composição farmacéutica processo para a preparação de um composto e uso
BR9806778B1 (pt) derivado de benzoìla substituìda por 3-heterociclila, composto, processo para a preparação do dito derivado de benzoìla substituìda por 3-heterociclila, derivado de ácido benzóico substituìdo por 3-heterociclila, composição e uso do referido derivado de benzoìla substutuìda por 3-heterociclila.
BR1100850A (pt) Composto, processo para a preparação de um composto, e, composição farmacêutica
BR9906934B1 (pt) composto, catalisador, processo para preparar uma poliolefina, e, uso de um catalisador.
BR9810116B1 (pt) composição de solução e processo para sua preparação.
BR9803720B1 (pt) composto de pigmento de quinoxalina-monoazo-acetarilida, processo para a preparação e uso do mesmo.
BR1100323A (pt) Composto, uso de um composto, composição farmacêutica e processo para preparar um composto
BR0113494B1 (pt) processo para a preparaÇço de uma formulaÇço sàlida herbicida, e, uso de uma formulaÇço sàlida herbicida.
BR9801652B1 (pt) resorcinil-triazina, processo para preparaÇço e uso da mesma e composiÇço cosmÉtica.
BR9711311B1 (pt) derivado de 1,2,3,4-tetrahidroquinolina, composiÇço farmaceutica, uso de um derivado de 1,2,3,4-tetrahidroquinolina, e, processo para a preparaÇço de compostos.
BR9804378B1 (pt) compostos, processo para sua produção e uso.
BR9404809A (pt) Composto, uso, formulação farmacêutica e processo para preparar um composto
BR9806786B1 (pt) processo para a preparaÇço de um Éter de mono-fléor-metila.
BR9808037B1 (pt) mistura de sàlidos, e, processo para a preparaÇço de formulaÇÕes herbicidas.
BR9906373B1 (pt) compostos pirimidinona, composições farmacêuticas contendo os compostos e processos para a preparação dos mesmos.

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: CORNELL RESEARCH FOUNDATION, INC. (US) , AVERA PHA

Free format text: TRANSFERIDO DE: GLAXO GROUP LIMITED

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 24/08/2010, OBSERVADAS AS CONDICOES LEGAIS.

B25G Requested change of headquarter approved

Owner name: CORNELL RESEARCH FOUNDATION, INC. (US) , AVERA PHA

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020110116524/RJ DE 11/11/2011.

B25A Requested transfer of rights approved

Owner name: CORNELL RESEARCH FOUNDATION, INC. (US) , MARUISHI

Free format text: TRANSFERIDO DE: AVERA PHARMACEUTICALS, INC.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2307 DE 24-03-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.